微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3.17% | 24.31% | 138.35% | 84/159 | 1.22% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 1.33% | -20.83% | 43.01% | 90/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.93% | -17.7% | -39.22% | 83/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 1.53% | -82.98% | -40% | 93/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 2.55% | -68.01% | 51.79% | 92/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.68% | -68.48% | 48.67% | 91/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.13% | -69.95% | -87.43% | 91/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 8.99% | -42% | 12.8% | 34/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 7.97% | -45.41% | 49.53% | 40/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.33% | -38.67% | 41.76% | 39/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.76% | -22.47% | -75.74% | 21/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 15.5% | -6.34% | 6.16% | 17/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 14.6% | -3.95% | 68.01% | 11/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 8.69% | 0.35% | 79.18% | 19/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 4.85% | 17.72% | -70.69% | 14/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 16.55% | -10.83% | 8.88% | 18/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 15.2% | -15.88% | 75.52% | 12/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.66% | -20.04% | 110.19% | 19/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 4.12% | -9.05% | -77.8% | 19/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 18.56% | -33.57% | 2.71% | 22/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 18.07% | 2% | 66.85% | 8/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 10.83% | 0.74% | 139.07% | 14/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 4.53% | 2% | -83.79% | 15/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 27.94% | 21.58% | 159.91% | 8/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 10.75% | 2% | -53.22% | 12/159 | 4.96% | 奥赛康 | 35% | 行业排名> |
| 2018-12-31 | 22.98% | 44.26% | 44.26% | 9/159 | 6.99% | 奥赛康 | 28.15% | 行业排名> |
| 2017-12-31 | 15.93% | -10.51% | -10.51% | 21/159 | 9.61% | 宏源药业 | 21.91% | 行业排名> |
| 2016-12-31 | 17.8% | 2% | 2% | 28/159 | 6.19% | 奥赛康 | 9.7% | 行业排名> |